Bubs Australia Limited ACN 060 094 742 23-29 Nina Link, Dandenong South VIC 3175 Australia 1800 2827 2878 (1800 BUBS AUST) info@bubsaustralia.com ASX ANNOUNCEMENT Permanent FDA Authorisation Webinar Notification 8 September 2026, Melbourne: Bubs Australia Limited (ASX: BUB) (“Bubs” or...
FDA Approval Webinar Notification
Filed with ASX · · 1 page · English
Watch Bubs Australia's latest callBubs Australia (ASX:BUB) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Bubs Australia (ASX:BUB) Q4 2026 Earnings CallRelease
In the deck
Earlier from Bubs Australia
- Bubs Secures Permanent US FDA Approval for Infant Formula
- Trading Halt
- Pause in Trading
- Change of Director's Interest Notice - LTM
- Change of Director's Interest Notice - PDP
Later from Bubs Australia
- FDA Approval Webinar Presentation
- Response to ASX Aware Query
- Date of AGM and Closing Date for Director Nominations
- Change of Director's Interest Notice - PJ
- Application for quotation of securities - BUB
Follow Bubs Australia into a list and get an email when it puts out news.
Follow Bubs Australia